Compare Sterling Biotech with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ORCHID PHARMA - Comparison Results

STERLING BIOTECH     Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH ORCHID PHARMA STERLING BIOTECH/
ORCHID PHARMA
 
P/E (TTM) x -0.4 -75.9 - View Chart
P/BV x 0.0 21.8 0.1% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   ORCHID PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ORCHID PHARMA
Sep-13
STERLING BIOTECH/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs11194 5.4%   
Low Rs335 9.7%   
Sales per share (Unadj.) Rs26.8276.5 9.7%  
Earnings per share (Unadj.) Rs-15.0-79.2 18.9%  
Cash flow per share (Unadj.) Rs-5.5-43.5 12.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.953.9 101.8%  
Shares outstanding (eoy) m267.8770.45 380.2%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x0.30.4 62.6%   
Avg P/E ratio x-0.5-1.4 32.1%  
P/CF ratio (eoy) x-1.3-2.6 48.3%  
Price / Book Value ratio x0.12.1 6.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8628,067 23.1%   
No. of employees `0001.42.8 48.4%   
Total wages/salary Rs m5472,527 21.6%   
Avg. sales/employee Rs Th5,303.36,956.1 76.2%   
Avg. wages/employee Rs Th403.8902.5 44.7%   
Avg. net profit/employee Rs Th-2,959.0-1,993.0 148.5%   
INCOME DATA
Net Sales Rs m7,18119,477 36.9%  
Other income Rs m43407 10.5%   
Total revenues Rs m7,22319,884 36.3%   
Gross profit Rs m9471,103 85.9%  
Depreciation Rs m2,5432,519 101.0%   
Interest Rs m4,3775,227 83.7%   
Profit before tax Rs m-5,931-6,236 95.1%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m-1,924-125 1,537.0%   
Profit after tax Rs m-4,007-5,580 71.8%  
Gross profit margin %13.25.7 232.9%  
Effective tax rate %32.42.0 1,616.1%   
Net profit margin %-55.8-28.7 194.7%  
BALANCE SHEET DATA
Current assets Rs m14,33511,014 130.1%   
Current liabilities Rs m49,80932,060 155.4%   
Net working cap to sales %-494.0-108.1 457.2%  
Current ratio x0.30.3 83.8%  
Inventory Days Days40395 425.2%  
Debtors Days Days17134 508.5%  
Net fixed assets Rs m55,43229,440 188.3%   
Share capital Rs m268705 38.0%   
"Free" reserves Rs m13,9352,043 682.2%   
Net worth Rs m14,7013,800 386.9%   
Long term debt Rs m9,4789,018 105.1%   
Total assets Rs m73,98846,510 159.1%  
Interest coverage x-0.4-0.2 183.8%   
Debt to equity ratio x0.62.4 27.2%  
Sales to assets ratio x0.10.4 23.2%   
Return on assets %0.5-0.8 -65.9%  
Return on equity %-27.3-146.9 18.6%  
Return on capital %-6.4-3.7 172.1%  
Exports to sales %25.937.9 68.4%   
Imports to sales %0.222.6 0.8%   
Exports (fob) Rs m1,8607,378 25.2%   
Imports (cif) Rs m124,406 0.3%   
Fx inflow Rs m1,8607,513 24.8%   
Fx outflow Rs m255,649 0.4%   
Net fx Rs m1,8351,865 98.4%   
CASH FLOW
From Operations Rs m1,7191,682 102.2%  
From Investments Rs m-3,148-9,860 31.9%  
From Financial Activity Rs m1,4266,644 21.5%  
Net Cashflow Rs m-3-1,535 0.2%  

Share Holding

Indian Promoters % 33.9 32.3 105.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 9.9 3.3 300.0%  
ADR/GDR % 16.9 4.6 367.4%  
Free float % 39.3 55.3 71.1%  
Shareholders   21,482 84,811 25.3%  
Pledged promoter(s) holding % 55.9 54.9 101.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   AJANTA PHARMA  GLENMARK PHARMA  SUN PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  

Compare STERLING BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

4 Reasons Why Sensex Surged 750 Points Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Top 5 Stocks Mutual Funds Bought and Sold in January 2021(Sector Info)

Feb 16, 2021

A look at what India's top equity mutual funds bought and sold in January 2021.

I Would Recommend this Small-cap Stock Over Tesla(Profit Hunter)

Feb 16, 2021

Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - WOCKHARDT COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS